Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01256619Phase 2Unknown
Phase 2, open-label trial of desogestrel in premenstrual syndrome (PMS), sponsored by Tehran University of Medical Sciences. Primary endpoint: Serum Lipids at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01256619.